TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34225318

Group type: EXPERIMENTAL
Intervention: Auditory Training (AT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Audiovisual Training (AVT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Combination of Auditory and Audiovisual Training (AT/AVT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (untrained talkers)
Number of subjects: 99
Study: 34034968

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perineural electrical dry needling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35893409

Group type: EXPERIMENTAL
Intervention: Diaphragm visual biofeedback by RUSI in conjunction with high-intensity IMT (RUSI+IMT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Isolated high-intensity IMT (IMT)
Number of subjects: 64
Study: 33051044

Group type: EXPERIMENTAL
Intervention: Exercise group (Ex)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Taurine supplementation + exercise group (TauEx)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Taurine supplementation group (Tau)
Number of subjects: 24
Study: 35986197

Group type: EXPERIMENTAL
Intervention: FDC (aripiprazole/divalproex sodium 5/500 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Aripiprazole 5mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Divalproex sodium 500mg
Number of subjects: 24
Study: 32063041

Group type: EXPERIMENTAL
Intervention: Electronic profiling/messaging combined with academic detailing intervention
Number of subjects: 5499

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 5499
Study: 36070132

Group type: EXPERIMENTAL
Intervention: TPIP 112.5 µg (n=6)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: TPIP 225 µg QD for 7 days (n=6)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: TPIP 112.5 µg QD for 4 days followed by 225 µg QD for 3 days (n=6)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (n=2 for single-dose, n=4 for multiple-dose)
Number of subjects: 42
Study: 33428219

Group type: EXPERIMENTAL
Intervention: Telehealth care (TC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 0
Study: 32454191

Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy with Deep Inspiration Breath Hold (IMRT-DIBH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3-Dimensional Conformal Radiation Therapy (3DCRT)
Number of subjects: 40
Study: 36471430

Group type: EXPERIMENTAL
Intervention: Symptom-driven ICS/LABA management strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional maintenance ICS treatment and symptom-driven SABA
Number of subjects: 0
Study: 33300950

Group type: EXPERIMENTAL
Intervention: Capecitabine (650 mg/m2 twice a day for 1 year)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 443
Study: 33227646

Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study: 35759328

Group type: EXPERIMENTAL
Intervention: Evidence-based chatbot intervention (IG)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 513
Study: 32810293

Group type: EXPERIMENTAL
Intervention: IDF criteria for MetS diagnosis
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Duncan et al, Rodriguez‐Moran et al, Cruz and Goran criteria for MetS diagnosis
Number of subjects: 981

Group type: COMPARATOR
Intervention: Prevalence of MetS in boys
Number of subjects: 981

Group type: COMPARATOR
Intervention: Prevalence of MetS in girls
Number of subjects: 981

Group type: COMPARATOR
Intervention: Concordance values for girls
Number of subjects: 981
Study: 35032862

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Class III obese
Number of subjects: 100
Study: 34158057

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 2418

Group type: COMPARATOR
Intervention: No insulin treatment
Number of subjects: 2418

Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 2418
Study: 35341380

Group type: EXPERIMENTAL
Intervention: Group music intervention (12 sessions over 4 weeks)
Number of subjects: 19
Study: 35538396

Group type: EXPERIMENTAL
Intervention: Point-of-care (PoC) HCV RNA testing and direct-acting antiviral (DAA) treatment
Number of subjects: 1410

Group type: COMPARATOR
Intervention: Conventional care (referral to local clinics)
Number of subjects: 1410
Study: 32349879

Group type: EXPERIMENTAL
Intervention: Ceftazidime/Avibactam (CAZ-AVI) followed by colistin + high-dose meropenem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meropenem followed by colistin + high-dose meropenem
Number of subjects: 0
Study: 33555941

Group type: EXPERIMENTAL
Intervention: R2CHOP
Number of subjects: 280

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 280
Study: 32482455

Group type: EXPERIMENTAL
Intervention: EX‐MEAL (exercise + lunch)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MEAL‐EX (lunch + exercise)
Number of subjects: 17

Group type: COMPARATOR
Intervention: CON (rest + lunch)
Number of subjects: 17
Study: 35956366

Group type: COMPARATOR
Intervention: WB + whole kiwifruit pulp (WB+KF)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: WB + neutralised kiwifruit pulp (WB+KFneut)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: WB + low‐fibre kiwifruit juice (WB+KFjuice)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: WB + KFsug + kiwifruit organic acids (WB+KFsug+OA)
Number of subjects: 9
Study: 33527721

Group type: EXPERIMENTAL
Intervention: 600 mg/d Alpha Lipoic Acid (ALA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (corn starch)
Number of subjects: 26
Study: 32698855

Group type: EXPERIMENTAL
Intervention: Closed drainage
Number of subjects: 420

Group type: COMPARATOR
Intervention: Non-drainage
Number of subjects: 420
Study: 34989288

Group type: EXPERIMENTAL
Intervention: Enhanced consent procedures (ECPs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 33647676

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 110
Study: 33257420

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 91356

Group type: COMPARATOR
Intervention: Non-use of Metformin
Number of subjects: 91356
Study: 35840293

Group type: EXPERIMENTAL
Intervention: Home-based AF screening using a handheld single-lead ECG recorder and a smartphone application.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care without home-based AF screening).
Number of subjects: 0
Study: 32493290

Group type: EXPERIMENTAL
Intervention: ProRoot MTA (MTA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: RetroMTA (RMTA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: RetroMTA + DBA (RMTA-B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ProRoot + DBA (MTA-B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (composite resin only)
Number of subjects: 50
Study: 36048793

Group type: EXPERIMENTAL
Intervention: STRETCH
Number of subjects: 21

Group type: COMPARATOR
Intervention: TRAD
Number of subjects: 21
Study: 34789234

Group type: EXPERIMENTAL
Intervention: Watch Me Grow‐ Electronic (WMG‐E) intervention group with continuity of care and additional in‐person assessment by a service navigator.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Care-as-usual group receiving electronic direction to relevant resources.
Number of subjects: 300
Study: 32568447

Group type: EXPERIMENTAL
Intervention: Let's Move It intervention
Number of subjects: 21
Study: 36133316

Group type: EXPERIMENTAL
Intervention: Initial L‐T4 dose of 10‐12.5 μg/kg/day (Low)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Initial L‐T4 dose of 12.6‐15 μg/kg/day (High)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Both treatment schemes (Low and High)
Number of subjects: 45
Study: 33624275

Group type: EXPERIMENTAL
Intervention: Intravenous Tranexamic Acid (TXA) administered as 1 gram bolus and 1 gram every 6 hours for 48 hours
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo administered in the same way as TXA
Number of subjects: 94
Study: 35180779

Group type: EXPERIMENTAL
Intervention: Behavioral sleep treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment-as-usual attention-controlled comparison group
Number of subjects: 30
Study: 33691506

Group type: EXPERIMENTAL
Intervention: Daily steps at 2 months poststroke (≥1632 daily steps)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Daily steps at 2 months and balance (Berg Balance Scale score)
Number of subjects: 206
Study: 32792614

Group type: EXPERIMENTAL
Intervention: 12 hours of normobaric hypoxia (3,000 m)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1 hour of normobaric hypoxia (3,000 m)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 40
Study: 34623205

Group type: EXPERIMENTAL
Intervention: Post-exposure exercise
Number of subjects: 99

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 99
Study: 34260986

Group type: EXPERIMENTAL
Intervention: Home‐based multimodal exercise program (AD‐HOMEX), 16 weeks, 3 sessions per week, 60 minutes each session
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Home‐based multimodal exercise program (AD‐HOMEX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study: 35578345

Group type: EXPERIMENTAL
Intervention: Implementation of the Clinical Decision Support System (CDSS) for hypertension management
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Different initial mono- or dual-antihypertensive therapy (nested trial LIGHT-ACD)
Number of subjects: 94
Study: 33660924

Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg/day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32227128

Group type: EXPERIMENTAL
Intervention: Routine invasive management strategy
Number of subjects: 8518

Group type: COMPARATOR
Intervention: Conservative management strategy
Number of subjects: 8518

Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 8518

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 8518
Study: 616556944

Group type: EXPERIMENTAL
Intervention: Just-in-time training (JITT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional training (TT)
Number of subjects: 0
Study: 35690880

Group type: EXPERIMENTAL
Intervention: Index partner HIV self-test (HIVST)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 180
Study: 33648572

Group type: EXPERIMENTAL
Intervention: Relaxing 360-degree immersive virtual reality content played inside a head-mounted display with noise-cancelling headphones, three times a day
Number of subjects: 920

Group type: COMPARATOR
Intervention: Standard ICU care
Number of subjects: 920
Study: 35322393

Group type: EXPERIMENTAL
Intervention: Vibrating insole device (VS) with 22-min daily vibrating sequences at 90% of tactile threshold
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (C) using the same device but with noise set to 0
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Vibrating insole device (VS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 56
Study: 33255731

Group type: EXPERIMENTAL
Intervention: FM containing Lactobacillus helveticus SBT2171 (LH2171)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo FM
Number of subjects: 200
Study: 616996904

Group type: EXPERIMENTAL
Intervention: Mirabegron (200 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Propranolol (160 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bisoprolol (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34547750

Group type: EXPERIMENTAL
Intervention: New intelligibility test based on acoustic-phonetic decoding of pseudowords
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (39 healthy participants)
Number of subjects: 117
Study: 33617797

Group type: EXPERIMENTAL
Intervention: Cervical length measurement
Number of subjects: 12407

Group type: EXPERIMENTAL
Intervention: Funneling
Number of subjects: 12407

Group type: EXPERIMENTAL
Intervention: Intraamniotic debris
Number of subjects: 12407
Study: 32240013

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (16 mmol nitrate/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitrate-depleted placebo
Number of subjects: 16
Study: 35353651

Group type: EXPERIMENTAL
Intervention: PHBC (phospholipidic-curcumin complex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34363761

Group type: EXPERIMENTAL
Intervention: GARD (genomic-adjusted radiation dose)
Number of subjects: 1615

Group type: COMPARATOR
Intervention: Physical dose of radiation
Number of subjects: 1615

Group type: COMPARATOR
Intervention: Sham-GARD (standard-of-care dose without radiotherapy)
Number of subjects: 1615
Study: 36135432

Group type: EXPERIMENTAL
Intervention: Isometric handgrip at 60% maximal voluntary contraction (IHG-60)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Isometric handgrip at 30% maximal voluntary contraction (IHG-30)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 39
Study: 33346349

Group type: EXPERIMENTAL
Intervention: Online communication training program
Number of subjects: 7

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 7
Study: 33371043

Group type: EXPERIMENTAL
Intervention: 9-month all-oral bedaquiline-containing regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: 9-month injectable-containing regimen
Number of subjects: 0
Study: 34847610

Group type: EXPERIMENTAL
Intervention: Lu AG06466 (40 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33663043

Group type: EXPERIMENTAL
Intervention: Automated feedback during CPR
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Feedback withdrawal after initial feedback
Number of subjects: 40
Study: 35370101

Group type: EXPERIMENTAL
Intervention: Penile prosthesis implantation with suspensory ligament release and pubic lipectomy via penopubic Z-plasty (group A)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional penile prosthesis implantation via penoscrotal incision (group B)
Number of subjects: 61
Study: 33375429

Group type: EXPERIMENTAL
Intervention: Antioxidant mix (bacopa, lycopene, astaxanthin, and vitamin B12)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 80
Study: 36122965

Group type: EXPERIMENTAL
Intervention: SBIRT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study: 33631141

Group type: EXPERIMENTAL
Intervention: Solriamfetol 37.5 mg/d
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Solriamfetol 75 mg/d
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Solriamfetol 150 mg/d
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg/d
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 32725398

Group type: EXPERIMENTAL
Intervention: AR-HMD (augmented reality head-mounted display)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard procedure without visual overlay
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Qualitative study with AR-HMD
Number of subjects: 20
Study: 36052011

Group type: EXPERIMENTAL
Intervention: AYURAKSHA kit (Sanshamani Vati, AYUSH Kadha, Anu Taila)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: AYURAKSHA kit
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study: 35960174

Group type: COMPARATOR
Intervention: Standard technique/lidocaine injection
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: New device/lidocaine patch
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: New device/lidocaine injection
Number of subjects: 225
Study: 33663566

Group type: EXPERIMENTAL
Intervention: Tight Control of psoriatic arthritis (TICOPA) trial with a treat to target (T2T) strategy consisting of 4-weekly review and escalation of therapy (single DMARD, combination DMARDs, and then biologics) based on remission criteria.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T2T approach within routine care in the MONITOR-PsA cohort.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T2T approach supported when monitoring treatment within the cohort.
Number of subjects: 0
Study: 32233189

Group type: EXPERIMENTAL
Intervention: Bioabsorbable polylactic acid membrane (PLA group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Acellular dermal matrix membrane guided bone regeneration (ADMG group)
Number of subjects: 20
Study: 34907431

Group type: EXPERIMENTAL
Intervention: INDI-FREEZE group (individualized protocol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (fixed protocol)
Number of subjects: 100
Study: 32191657

Group type: EXPERIMENTAL
Intervention: Midodrine 5mg before meals for one month
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34978231

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT) intervention for 10 sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33468225

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MCI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1000
Study: 33317579

Group type: EXPERIMENTAL
Intervention: High flow nasal therapy (HFNT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 79
Study: 32596788

Group type: EXPERIMENTAL
Intervention: Second dose of ecological executive skills training (EEST)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 70
Study: 32035706

Group type: EXPERIMENTAL
Intervention: PHiD-CV vaccination schedule (3+1) for HIV+ and HEU children; primary vaccination at 6/10/14 weeks and booster at 9-10 months.
Number of subjects: 484

Group type: COMPARATOR
Intervention: HUU/3+1 (3-dose priming and booster), HUU/3+0 (3-dose priming without booster), HUU/2+1 (2-dose priming and booster).
Number of subjects: 484
Study: 33484839

Group type: EXPERIMENTAL
Intervention: Coenrolment permitted
Number of subjects: 219

Group type: COMPARATOR
Intervention: Coenrolment not permitted
Number of subjects: 219
Study: 34057299

Group type: EXPERIMENTAL
Intervention: Fractionated weekly DCF (D 40 mg/m2, C 35 mg/m², F 1800 mg/m² over 24 h, on days 1 and 8 every 3 weeks)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Fortnightly DCF (D 50 mg/m2, C 50 mg/m², F 2000 mg/m² over 48 h every 2 weeks)
Number of subjects: 106
Study: 36093809

Group type: EXPERIMENTAL
Intervention: Positive Action (PA) program
Number of subjects: 1200
Study: 34154637

Group type: EXPERIMENTAL
Intervention: Web-based intervention based on the Health Action Process Approach (HAPA) with immediate access after baseline assessment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with access to the web-based intervention only after follow-up assessment.
Number of subjects: 0
Study: 32106344

Group type: EXPERIMENTAL
Intervention: Synthetic mesh repair (mesh group, n=63)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Native tissue repair (native tissue group, n=59)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Synthetic mesh repair (mesh group)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Native tissue repair (native tissue group)
Number of subjects: 122
Study: 35040014

Group type: EXPERIMENTAL
Intervention: MAP training (6 weeks, 30 min meditation + 30 min aerobic exercise, once a week)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 26
Study: 34739914

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF) treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34875965

Group type: EXPERIMENTAL
Intervention: Audio hypnotherapy for 15 minutes
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care (rest for about 15 minutes)
Number of subjects: 64
Study: 33289663

Group type: EXPERIMENTAL
Intervention: Tigecycline (off label use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tigecycline (for pneumonia)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tigecycline (various off label uses)
Number of subjects: 0
Study: 34281921

Group type: EXPERIMENTAL
Intervention: SOFIA intervention (eHealth intervention including SOFIA-Monitoring and SOFIA-Coaching)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-SOFIA (control group)
Number of subjects: 0
Study: 35015210

Group type: EXPERIMENTAL
Intervention: Ulipristal 10-mg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Combination oral contraceptive (COC)
Number of subjects: 28
Study: 32931821

Group type: EXPERIMENTAL
Intervention: 8-week behavior change intervention aimed at increasing physical activity
Number of subjects: 51

Group type: COMPARATOR
Intervention: usual care and disease-specific education (Control Group)
Number of subjects: 51
Study: 32393216

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE)
Number of subjects: 945
Study: 35346380

Group type: EXPERIMENTAL
Intervention: MyComrade intervention delivered by pairs of general practitioners (GPs) in ROI, and a GP and practice-based pharmacist (PBP) in NI.
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care in control practices.
Number of subjects: 320
Study: 34776826

Group type: EXPERIMENTAL
Intervention: diet + Sapere-method
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: diet
Number of subjects: 144

Group type: COMPARATOR
Intervention: control group
Number of subjects: 144
Study: 35818198

Group type: EXPERIMENTAL
Intervention: Felodipine and enalapril
Number of subjects: 110

Group type: COMPARATOR
Intervention: Felodipine
Number of subjects: 110
Study: 34127361

Group type: EXPERIMENTAL
Intervention: eComp
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard tangential fields
Number of subjects: 40